Sanofi
Compositions and Methods for Muscle Progenitor Cell-Based Therapies

Last updated:

Abstract:

Disclosed herein are methods and compositions that provide for improved production and efficacy of cell-based therapies. For example, the culture of muscle progenitor cells (satellite cells) on laminin 521 is provided as a means to maintain differentiation and engraftment potential of the cells, e.g. for therapeutic purposes.

Status:
Application
Type:

Utility

Filling date:

27 Jul 2017

Issue date:

22 Aug 2019